DK1352658T3 - Forebyggelse eller lægemiddel mod endometriose - Google Patents

Forebyggelse eller lægemiddel mod endometriose

Info

Publication number
DK1352658T3
DK1352658T3 DK01271228.7T DK01271228T DK1352658T3 DK 1352658 T3 DK1352658 T3 DK 1352658T3 DK 01271228 T DK01271228 T DK 01271228T DK 1352658 T3 DK1352658 T3 DK 1352658T3
Authority
DK
Denmark
Prior art keywords
prevention
drug
endometriosis
therapy
effective
Prior art date
Application number
DK01271228.7T
Other languages
English (en)
Inventor
Masao Sugamata
Original Assignee
Tochigi Inst Of Clinical Patho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tochigi Inst Of Clinical Patho filed Critical Tochigi Inst Of Clinical Patho
Application granted granted Critical
Publication of DK1352658T3 publication Critical patent/DK1352658T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Seal Device For Vehicle (AREA)
DK01271228.7T 2000-12-18 2001-12-18 Forebyggelse eller lægemiddel mod endometriose DK1352658T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000383224A JP4074427B2 (ja) 2000-12-18 2000-12-18 子宮内膜症の予防又は治療薬
PCT/JP2001/011069 WO2002049670A1 (fr) 2000-12-18 2001-12-18 Medicaments preventifs ou remedes pour l'endometriose

Publications (1)

Publication Number Publication Date
DK1352658T3 true DK1352658T3 (da) 2010-09-20

Family

ID=18850916

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01271228.7T DK1352658T3 (da) 2000-12-18 2001-12-18 Forebyggelse eller lægemiddel mod endometriose

Country Status (13)

Country Link
US (2) US7585854B2 (da)
EP (1) EP1352658B1 (da)
JP (1) JP4074427B2 (da)
KR (3) KR100915124B1 (da)
CN (1) CN100379455C (da)
AT (1) ATE469642T1 (da)
AU (2) AU2267602A (da)
CA (1) CA2432177C (da)
DE (1) DE60142308D1 (da)
DK (1) DK1352658T3 (da)
ES (1) ES2343674T3 (da)
HK (1) HK1064944A1 (da)
WO (1) WO2002049670A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799766B2 (en) * 1998-04-08 2010-09-21 Theta Biomedical Consulting & Development Co., Inc. Composition for treating hormonally-dependent cancers
JPWO2005058878A1 (ja) * 2003-12-16 2007-07-12 小野薬品工業株式会社 月経困難症の予防および／または治療剤
US20050220912A1 (en) * 2004-03-30 2005-10-06 Theoharides Theoharis C Anti-inflammatory composition for treating pelvic endometriosis
EP1810690B1 (en) 2004-10-28 2012-01-18 Kyowa Hakko Kirin Co., Ltd. Anti-IL-5 receptor antibody for use in treating endometriosis.
US20110092463A1 (en) * 2008-04-07 2011-04-21 Johan Raud Combination for use in the treatment of inflammatory disorders
DE202008009280U1 (de) 2008-07-10 2008-09-11 Beumer Gmbh & Co. Kg Fördervorrichtung mit entgegen der Verfahrrichtung antreibbarer Abschiebeeinrichtung
AU2010260885B2 (en) * 2009-06-17 2015-03-12 Keio University Prophylactic and/or therapeutic agent for dysmenorrhea
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
JP5500051B2 (ja) * 2010-11-22 2014-05-21 富士通セミコンダクター株式会社 強誘電体メモリ
KR102677330B1 (ko) * 2022-01-21 2024-06-20 건양대학교 산학협력단 Tbk1 억제제를 포함하는 태반 염증의 예방 또는 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID26390A (id) * 1997-12-23 2000-12-21 Schering Corp Komposisi untuk pengobatan pernapasan dan penyakit kulit sekurangnya terdiri dari satu leukotrien antagonis dan satu antihistamin
JP4378580B2 (ja) * 1999-11-02 2009-12-09 ソニー株式会社 インクリボンカセット

Also Published As

Publication number Publication date
US7585854B2 (en) 2009-09-08
DE60142308D1 (de) 2010-07-15
AU2267602A (en) 2002-07-01
KR101064543B1 (ko) 2011-09-14
KR20030062431A (ko) 2003-07-25
KR100915124B1 (ko) 2009-09-03
US20040024016A1 (en) 2004-02-05
EP1352658B1 (en) 2010-06-02
US20090227564A1 (en) 2009-09-10
KR20080077027A (ko) 2008-08-20
KR20090107547A (ko) 2009-10-13
CA2432177C (en) 2011-02-15
AU2002222676B2 (en) 2006-06-01
ES2343674T3 (es) 2010-08-06
JP2002187855A (ja) 2002-07-05
CN100379455C (zh) 2008-04-09
JP4074427B2 (ja) 2008-04-09
HK1064944A1 (en) 2005-02-08
CN1489475A (zh) 2004-04-14
EP1352658A1 (en) 2003-10-15
ATE469642T1 (de) 2010-06-15
EP1352658A4 (en) 2005-01-12
KR101026707B1 (ko) 2011-04-08
WO2002049670A1 (fr) 2002-06-27
CA2432177A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
DE60122196D1 (de) Synergistische antioxidans-kombination von delta tocols und polyphenolen
PT1235799E (pt) Forma polimorfica de atorvastatina-calcio
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
NO2011026I1 (no) Eribulin og farmasøytisk akseptable salter derav
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MXPA00011422A (es) Derivados de bencimidazol como moduladores de ige.
DE60041761D1 (de) Tribonektine
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
DK1352658T3 (da) Forebyggelse eller lægemiddel mod endometriose
EE200200717A (et) Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid
DE60121461D1 (de) Kondensierte pyridoindolderivate
AR034343A1 (es) Combinaciones farmaceuticas
ATE263171T1 (de) Neue derivate und analoga von galanthamin
ATE417617T1 (de) Mittel zur steurung der expression von il-12
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
ATE374203T1 (de) Therapeutische verbindungen und verfahren
DE60034770D1 (de) Stabile fumagillin-formulierung
DE60139892D1 (de) Makrolidantibiotika für endometriose oder uterusmyome
DE60136706D1 (de) Ycin-acryloyl derivate und antimetabolische mitteln
UY27376A1 (es) Formulación de medicamento que contiene un antagonista de ltb4
UA38786A (uk) Фібринолітичний засіб